SCHEMBL22103000

SCHEMBL22103000

O=c1nc(NC2C[C@@H]2F)c2ccc(C(F)(F)F)cc2n1-c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ MAT2A P31153 19/20 0.57
▸ MAT1A Q00266 1/20 0.41
▸ TDP2 O95551 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22103169 1.00 MAT2A (0.57) MAT2AMAT1ATDP2
SCHEMBL22103546 1.00 MAT2A (0.57) MAT2AMAT1ATDP2
SCHEMBL30894473 1.00 MAT2A (0.57) MAT2AMAT1ATDP2
SCHEMBL30894483 1.00 MAT2A (0.57) MAT2AMAT1ATDP2
SCHEMBL22093381 1.00 MAT2A (0.57) MAT2AMAT1ATDP2
SCHEMBL23583455 1.00 MAT2A (0.57) MAT2AMAT1ATDP2
SCHEMBL22093380 1.00 MAT2A (0.57) MAT2AMAT1ATDP2
SCHEMBL22103363 0.87 MAT2A (0.59) MAT2AMAT1A
SCHEMBL22093266 0.87 MAT2A (0.54) MAT2AMAT1ATDP2
SCHEMBL22103111 0.86 MAT2A (0.50) MAT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022256806-A1 COMBINATION THERAPY COMPRISING A MAT2A INHIBITOR AND A TYPE II PRMT INHIBITOR IDEAYA BIOSCIENCES, INC. (US) 2022-12-08 — — WO disclosed
WO-2020123395-A1 2-OXOQUINAZOLINE DERIVATIVES AS METHIONINE ADENOSYLTRANSFERASE 2A INHIBITORS IDEAYA BIOSCIENCES, INC. (US) 2020-06-18 — — WO disclosed
Send feedback